Wolverine Trading’s Lisata Therapeutics LSTA Stock Holding History

Wolverine Trading’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,500	Closed	-$26K	–	6435
2021 Q3	$26K	Buy	+1,500	New	+$29.4K	﹤0.01%	6117

Other funds holding LSTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's LSTA Position: Q4 2021 in Review

Wolverine Trading sold out of Lisata Therapeutics (LSTA) in Q4 2021, closing a stake of 1,735 shares — an estimated $30K sold.

Wolverine Trading first reported a position in LSTA in Q3 2021 and held it in 1 quarter. The position peaked at $30K in Q3 2021. 34 funds tracked by Wall St. Rank hold LSTA as of Q4 2021.

Wolverine Trading reported no remaining Lisata Therapeutics position as of Q4 2021 after selling out during the quarter.
Wolverine Trading sold 1,735 Lisata Therapeutics shares in Q4 2021, an estimated $30K.
Wolverine Trading first reported a position in Lisata Therapeutics in Q3 2021 and held it in 1 quarter.
Wolverine Trading's Lisata Therapeutics position peaked at $30K in Q3 2021.
34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.